Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
Keitel
E
E
Transplant Unit, Santa Casa de Porto Alegre, Rs, Brazil.
Bittar
A E
AE
Losekann
A
A
Deboni
L
L
Ceretta
F
F
Goldani
J C
JC
Garcia
V D
VD
D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage*; D016572:Cyclosporine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D016853:Muromonab-CD3 / Q000008:administration & dosage; D011183:Postoperative Complications / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D011241:Prednisone / Q000008:administration & dosage*; D015996:Survival Rate
D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone